Cambrian Biopharma is a private, clinical-stage biopharmaceutical company focused on developing therapies to prevent and cure age-related diseases. Cambrian is based in New York City with operations across the US and Europe. Cambrian Biopharma is a biotech venture capital holding company that helps scientists transmit their discoveries from the lab into the clinic. Cambrian is uniquely focused on a specific field of biomedical research: the biology of aging, also known as geroscience. Cambrian is built on an emerging business model that we call a ‘Distributed R&D Company’ or ‘DisCo’ that blends the best aspects of the venture capital firm with the capital efficient, agile domain expertise of a mid-sized biotech company. We partner with academic geroscientists to build companies, manage preclinical drug discovery, and finance clinical trials. We have launched 10 companies with leading geroscientists globally. Founded in 2019, Cambrian is a team of over 20 scientist-entrepreneurs, venture capitalists, pharma veterans, and drug hunters located in New York, San Diego, Oxford, Sydney, Frankfurt and London.Something looks off?